RRT With a Cytokine Absorption Filter (oXiris ®) in Patients With Septic Shock
Launched by CLINICA CES · Jul 2, 2021
Trial Information
Current as of May 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patients who enter the Intensive Care Unit of the CES Clinic during the recruitment period with:
- • Diagnosis of septic shock of any origin according to the definition of the Sepsis-3 consensus.
- • Acute renal injury according to the KDIGO 2012 classification that requires continuous renal replacement therapy and that its origin is presumed to be septic origin.
- • In invasive ventilatory support.
- • Informed consent previously filled out by a guardian.
- Exclusion Criteria:
- • Patients under 18 years of age and women in pregnancy or postpartum will be excluded.
- • Chronic kidney disease that requires RRT on an outpatient basis before admission to the ICU.
- • Contraindication to the use of heparins or another anticoagulant
- • Dissent to escalate therapeutic measures
- • Terminal or irrecoverable condition according to the criteria of the specialist in critical medicine and intensive care
About Clinica Ces
Clinica CES is a leading clinical research organization dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical trials. With a commitment to ethical practices and patient safety, Clinica CES collaborates with healthcare professionals, researchers, and sponsors to design and implement studies across various therapeutic areas. Their expertise in trial management, regulatory compliance, and data analysis ensures the efficient execution of high-quality research, contributing to the development of new therapies and treatments. By fostering a culture of collaboration and excellence, Clinica CES plays a pivotal role in the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Medellín, Antioquia, Colombia
Patients applied
Trial Officials
David Yepes-Gómez, MD, MSc
Principal Investigator
Clinica CES
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials